Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1CNS 1

Conditions

Influenza, Human 15Neoplasms 7Leukemia, Lymphocytic, Chronic, B-Cell 5Myelodysplastic Syndromes 4Leukemia, Myeloid, Acute 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Lymphoma 3Leukemia 3Colorectal Neoplasms 3Neoplasms, Plasma Cell 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Hodgkin Disease 2Central Nervous System Neoplasms 2Anemia, Aplastic 2Waldenstrom Macroglobulinemia 1Vaccine-Preventable Diseases 1Vaccination Hesitancy 1Skin Neoplasms 1Sezary Syndrome 1Serology Analysis 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Primary Myelofibrosis 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Patient Acceptance of Health Care 1Pancreatic Neoplasms 1

Interventions

Vincristine 12Temozolomide 11Irinotecan 10Cyclophosphamide 10Melphalan 8Filgrastim 8Etoposide 7Ifosfamide 6Granulocyte Colony-Stimulating Factor 6Doxorubicin 6Vinorelbine 5Gemcitabine 5Busulfan 5Thiotepa 4Radiotherapy 4Peripheral Blood Stem Cell Transplantation 4Dactinomycin 4pegfilgrastim 3liposomal doxorubicin 3irinotecan sucrosofate 3fludarabine 3etoposide phosphate 3Stem Cell Transplantation 3Sirolimus 3Proton Therapy 3Cisplatin 3Carboplatin 3Bone Marrow Transplantation 3thymoglobulin 2regorafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Rhabdomyosarcoma × Influenza Vaccines × Clear all
NCT01804634 2026-03-13

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting
60 enrolled
CNSGastrointestinalSarcoma

Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡